NGeneBio Co., Ltd. (KOSDAQ:354200)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,622.00
-98.00 (-5.70%)
At close: Sep 3, 2026

NGeneBio Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
3,0001,9434,43019,27524,89716,296
Short-Term Investments
1,054707.458.42129.0510,0218,011
Trading Asset Securities
2,4923,0253,0083,023--
Cash & Short-Term Investments
6,5465,6757,49622,42734,91824,307
Cash Growth
-45.98%-24.30%-66.57%-35.77%43.66%-
Accounts Receivable
12,85513,847699.76788.951,1251,574
Other Receivables
143.8172.9862.06210.7751.0958.06
Receivables
13,50714,428761.82999.721,1761,632
Inventory
1,6621,4232,0741,6952,9681,219
Prepaid Expenses
138.91366.84120.57121.5141.7279.67
Other Current Assets
854.552,4831,2201,7793,868136.73
Total Current Assets
22,70924,37711,67227,02143,07227,374
Property, Plant & Equipment
6,7186,42912,1729,3438,6848,092
Long-Term Investments
1,9821,9051,0572,8371,3785,451
Goodwill
3,2212,9835,388416.32416.32416.32
Other Intangible Assets
1,7601,9892,4271,4561,2241,247
Other Long-Term Assets
34,23434,655233.051,2081,3891,287
Total Assets
70,62372,33832,95042,28256,16443,867

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
5,2005,140376.67162.7569.18172.85
Accrued Expenses
309.55557.94476.88253.59235.99188.37
Short-Term Debt
32,48932,7776,75011,05610,7866,100
Current Portion of Long-Term Debt
3,512----362
Current Portion of Leases
308.26318.521,028241.11295.95161.89
Current Unearned Revenue
12.970.04-020.1718.33
Other Current Liabilities
8,8979,2133,89312,10317,5941,051
Total Current Liabilities
50,72948,00612,52523,81629,0018,055
Long-Term Debt
-----500
Long-Term Leases
77.8153.451,242146.88374.6282.69
Pension & Post-Retirement Benefits
1,0421,0881,4651,9351,2971,188
Other Long-Term Liabilities
87.65497.7710.19150.52165.3843.69
Total Liabilities
51,93749,74515,24126,04830,8379,869

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
8,93725,03819,81912,88912,52612,431
Additional Paid-In Capital
71,25269,03560,90955,10252,57051,982
Retained Earnings
-61,812-71,661-66,297-53,941-40,886-31,381
Comprehensive Income & Other
780.43554.092,5472,2441,086965.73
Total Common Equity
19,14522,96616,97716,29525,29733,998
Minority Interest
-458.39-373.77731.71-60.6830.24-
Shareholders' Equity
18,68622,59217,70916,23425,32733,998
Total Liabilities & Equity
70,62372,33832,95042,28256,16443,867

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
36,38733,2499,01911,44411,4567,207
Net Cash (Debt)
-29,842-27,574-1,52310,98323,46217,100
Net Cash Growth
----53.19%37.20%-
Net Cash Per Share
-3477.48-3678.51-322.182597.565640.724147.91
Filing Date Shares Outstanding
8.948.356.614.34.184.14
Total Common Shares Outstanding
8.948.356.614.34.184.14
Working Capital
-28,021-23,630-852.153,20514,07219,319
Book Value Per Share
2141.412751.752569.873792.666058.748204.81
Tangible Book Value
14,16417,9949,16214,42223,65632,334
Tangible Book Value Per Share
1584.292156.021386.833356.845665.847803.33
Land
1,9291,9292,6962,6962,5842,584
Buildings
2,8932,8934,0444,0443,0403,040
Machinery
6,6636,8908,4224,9624,5693,699
Construction In Progress
367.04---9.23-